|
KMID : 0363320010220040669
|
|
Journal of Korean Oriental Internal Medicine
2001 Volume.22 No. 4 p.669 ~ p.674
|
|
|
The Clinical study in 60 cases for breast cancer patients on the effects by Hnagamdan(抗癌丹)
|
|
Song Kee-Cheol
Choi Byung-Lyul
Lee Yong-Yeon
Yoo Hwa-Seung
Seo Sang-Hoon
Choi Woo-Jin
Cho Jung-Hyo
Lee Yeon-Weol
Son Chang-Gue
Cho Chong-Kwan
|
|
|
Abstract
|
|
|
Objectives: The purpose of this study was to examine the efficacy of Hangamdan(Kangaidan) on 60 patients who have suffered from breast cancer.
Methods: Hangamdan(Kangaidan) was administered to patients for over 1 months continuously. We checked improvement of clinical symptoms, changes of chemistry hematological test.
Results: The results obtained are summarized as follows. Hangamdan(Kangaidan) has significant effect on the improvement of clinical symptoms. The effects of maintenance and improvement in the symptoms with traditional oriental therapy(83.3%) and combined treatment of western and oriental therapy(92.1%) were observed. The effects of the symptoms were diarrhea(37.3%), abdominal pain (25.3%), general body weakness(22.9%), nausea(20.5%) and etc. in orders. And analysis of hematology attached by breast cancer, maintenance and increasing of WBC(89.9%), RBC(74.7%), Hgb(81.1%), Platelet(92.4%) were observed. After taken Hangamdan(Kangaidan), maintenance and decreasing of AST(85.9%), ALT(94.8%), -GTP(87.5%), BUN(88.3%), Creatinine(90.9%) were observed. And increasing of IL-12(25%), IFN-(83%) were observed.
Conclusions: From the above results, it is suggested that Hangamdan(Kangaidan) have significant effects on recovery of immune modulation.
|
|
|
KEYWORD
|
|
|
Breast cancer, Hangamdan(Hangaidan), IFN-γ, CA15-3
|
|
|
FullTexts / Linksout information
|
|
|
|
|
Listed journal information
|
|
|
|